Agency Information Collection Activities: Proposed Collection; Comment Request, 67466-67467 [2019-26594]
Download as PDF
67466
Federal Register / Vol. 84, No. 237 / Tuesday, December 10, 2019 / Notices
Modernization Act of 2003 (MMA) in
Subpart 3. The application requirements
are codified in Subpart K of 42 CFR 423
entitled ‘‘Application Procedures and
Contracts with PDP Sponsors.’’
The information will be collected
under the solicitation of proposals from
PDP, MA–PD, Cost Plan, Program of All
Inclusive Care for the Elderly (PACE),
and EGWP applicants. The collected
information will be used by CMS to: (1)
Ensure that applicants meet CMS
requirements for offering Part D plans
(including network adequacy,
contracting requirements, and
compliance program requirements, as
described in the application), (2)
support the determination of contract
awards. Form Number: CMS–10137
(OMB control number: 0938–0936);
Frequency: Yearly; Affected Public:
State, Local, or Tribal Governments;
Number of Respondents: 243; Total
Annual Responses: 290; Total Annual
Hours: 1,384.79. (For policy questions
regarding this collection contact
Arianne Spaccarelli at 410–786–5715.)
Dated: December 5, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2019–26595 Filed 12–9–19; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–304/–304a and
CMS–368/–R–144]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:08 Dec 09, 2019
Jkt 250001
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
February 10, 2020.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of the following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–304/–304a Reconciliation of
State Invoice and Prior Quarter
Adjustment Statement
CMS–368/–R–144 Medicaid Drug
Rebate Program Forms
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Reconciliation
of State Invoice (ROSI) and Prior
Quarter Adjustment Statement (PQAS);
Use: Form CMS–304 (ROSI) is used by
manufacturers to respond to the state’s
rebate invoice for current quarter
utilization. Form CMS–304a (PQAS) is
required only in those instances where
a change to the original rebate data
submittal is necessary. Form Number:
CMS–304 and –304a (OMB control
number: 0938–0676); Frequency:
Quarterly; Affected Public: Business or
other for-profits; Number of
Respondents: 1,255; Total Annual
Responses: 5,020; Total Annual Hours:
227,416. (For policy questions regarding
this collection contact Andrea
Wellington at 410–786–3490.)
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicaid Drug
Rebate State Reporting Program Forms;
Use: We develop the rebate amount per
drug unit from information supplied by
the drug manufacturers and distributes
these data to the states. States then must
report quarterly to the drug
manufacturers and report to us the total
number of units of each dosage form/
strength of their covered outpatient
drugs reimbursed during a quarter and
the rebate amount to be refunded. This
report is due within 60 days of the end
of each calendar quarter. The
information in the report is based on
claims paid by the state Medicaid
agency during a calendar quarter. Form
CMS–R–144 (Quarterly Report Data) is
required from states quarterly to report
utilization for any drugs paid for during
E:\FR\FM\10DEN1.SGM
10DEN1
Federal Register / Vol. 84, No. 237 / Tuesday, December 10, 2019 / Notices
that quarter. Form CMS–368
(Administrative Data) is required only
in those instances where a change to the
original data submittal is necessary.
Form Number: CMS–368 and –R–144
(OMB control number: 0938–0582);
Frequency: Quarterly and on occasion;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
56; Total Annual Responses: 234; Total
Annual Hours: 12,101. (For policy
questions regarding this collection
contact Shannon Evans at 410–786–
3083.)
Dated: December 5, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: December 4, 2019.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–26506 Filed 12–9–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2019–26594 Filed 12–9–19; 8:45 am]
National Cancer Institute; Notice of
Closed Meetings
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of NIGMS IDeA Program
Infrastructure for Clinical and Translational
Research (IDeA–CTR) (U54) Applications.
Date: March 6, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Diplomat/
Ambassador Conference Room, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Ruth Grossman, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18, Bethesda, MD
20892, (301) 435–2409, grossmanrs@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
VerDate Sep<11>2014
17:08 Dec 09, 2019
Jkt 250001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Pediatric
Brain Tumor Consortium.
Date: January 9, 2020.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Dr., Rm. 7W126,
Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Caron A. Lyman, Ph.D.,
Chief, Scientific Review Officer, National
Cancer Institute, NIH, Division of Extramural
Activities, Research Programs Review
Branch, 9609 Medical Center Dr., Rm.
7W126, Bethesda, MD 20892–9750, 240–276–
6348, lymanc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–6: NCI
Clinical and Translational R21 and Omnibus
R03.
Date: January 31, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North, Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Saejeong J. Kim, Ph.D.,
Scientific Review Officer, Special Review
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
67467
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W640, Rockville, MD
20850, 240–276–7684, saejeong.kim@nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; TEP–3: SBIR
Contract Review.
Date: February 6, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
5E030, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Eduardo Emilio Chufan,
Ph.D., Scientific Review Officer, Research
Technology & Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W254, Bethesda, MD 20892,
240–276–7975, chufanee@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Program Project (P01) Review I.
Date: February 12–13, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton BWI (Baltimore), 1100 Old
Elkridge Landing Road, Baltimore, MD
21090.
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, 9609
Medical Center Drive, Room 7W238, National
Cancer Institute, NIH, Bethesda, MD 20892–
9750, (240) 276–6371, decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
I—Transition to Independence.
Date: February 20–21, 2020.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal City Marriott, 1999 Jefferson
Davis Highway, Arlington, VA 22202.
Contact Person: Delia Tang, M.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W602,
Bethesda, MD 20892, (240) 276–6456, tangd@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP 5:
SBIR Contract Review.
Date: March 5, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W102, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, 9609
Medical Center Drive, Room 7W238, National
Cancer Institute, NIH, Bethesda, MD 20892–
9750, (240) 276–6371, decluej@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
E:\FR\FM\10DEN1.SGM
10DEN1
Agencies
[Federal Register Volume 84, Number 237 (Tuesday, December 10, 2019)]
[Notices]
[Pages 67466-67467]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-26594]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers: CMS-304/-304a and CMS-368/-R-144]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (the PRA), federal agencies are required to publish notice
in the Federal Register concerning each proposed collection of
information (including each proposed extension or reinstatement of an
existing collection of information) and to allow 60 days for public
comment on the proposed action. Interested persons are invited to send
comments regarding our burden estimates or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and clarity of the information to be
collected, and the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
DATES: Comments must be received by February 10, 2020.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number __, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of the following:
1. Access CMS' website address at website address at https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.html.
2. Email your request, including your address, phone number, OMB
number, and CMS document identifier, to [email protected].
3. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-304/-304a Reconciliation of State Invoice and Prior Quarter
Adjustment Statement
CMS-368/-R-144 Medicaid Drug Rebate Program Forms
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Reconciliation of
State Invoice (ROSI) and Prior Quarter Adjustment Statement (PQAS);
Use: Form CMS-304 (ROSI) is used by manufacturers to respond to the
state's rebate invoice for current quarter utilization. Form CMS-304a
(PQAS) is required only in those instances where a change to the
original rebate data submittal is necessary. Form Number: CMS-304 and -
304a (OMB control number: 0938-0676); Frequency: Quarterly; Affected
Public: Business or other for-profits; Number of Respondents: 1,255;
Total Annual Responses: 5,020; Total Annual Hours: 227,416. (For policy
questions regarding this collection contact Andrea Wellington at 410-
786-3490.)
2. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Medicaid Drug
Rebate State Reporting Program Forms; Use: We develop the rebate amount
per drug unit from information supplied by the drug manufacturers and
distributes these data to the states. States then must report quarterly
to the drug manufacturers and report to us the total number of units of
each dosage form/strength of their covered outpatient drugs reimbursed
during a quarter and the rebate amount to be refunded. This report is
due within 60 days of the end of each calendar quarter. The information
in the report is based on claims paid by the state Medicaid agency
during a calendar quarter. Form CMS-R-144 (Quarterly Report Data) is
required from states quarterly to report utilization for any drugs paid
for during
[[Page 67467]]
that quarter. Form CMS-368 (Administrative Data) is required only in
those instances where a change to the original data submittal is
necessary. Form Number: CMS-368 and -R-144 (OMB control number: 0938-
0582); Frequency: Quarterly and on occasion; Affected Public: State,
Local, or Tribal Governments; Number of Respondents: 56; Total Annual
Responses: 234; Total Annual Hours: 12,101. (For policy questions
regarding this collection contact Shannon Evans at 410-786-3083.)
Dated: December 5, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2019-26594 Filed 12-9-19; 8:45 am]
BILLING CODE 4120-01-P